Status:
COMPLETED
A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Inflammatory Rheumatic Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The screening for latent tuberculosis infection (LTBI) prior to the onset of anti-tumor necrosis factor therapy, as well as a watchful monitoring during the treatment, is strongly recommended. Tubercu...
Eligibility Criteria
Inclusion
- clinical diagnosis of inflammatory rheumatic diseases
- patients candidates to anti-TNF treatment
Exclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT01475409
Start Date
July 1 2008
End Date
February 1 2011
Last Update
November 21 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.